Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Novogen Limited (NasdaqNM:NVGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Recent Events
July 30Price hit new 52-week low ($3.35)
Location
140 Wicks Road, North Ryde
NSW 2113, Australia
Phone: (203) 327-1188
Fax: (203) 327-0011
Email: invest@novogen.com
Employees (last reported count): 68
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Healthcare Facilities
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 52%
·Institutional: 0% (0% of float)
(3 institutions)
·Net Inst. Selling: 1,000  shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Novogen Limited is an international pharmaceutical company. The Company's work began with naturally occurring isoflavones found in the human diet, which has since led to the discovery and development of phenolic therapeutic technology. Isoflavones are a group of phytoestrogens found only in legumes like chickpeas, red clover and lentils. Currently, Novogen has three products available. All products are dietary supplements containing four natural isoflavones, formononetin, daidzein, biochanin A and genistein (the four isoflavones), which are considered the most significant in terms of estrogenic properties. Promensil is indicated for the management of menopausal symptoms. Rimostil promotes bone and heart health in women. Trinovin has been developed specifically for the maintenance of the health of men, especially those over the age of 50.
More from Market Guide: Expanded Business Description

Financial Summary
Novogen Limited is engaged in pharmaceutical research and development and manufacturing and marketing of health supplements. For the fiscal year ended 6/30/1999, revenues totalled A$20.9 million, up from A$6.4 million. Net loss according to US GAAP totalled A$17.9 million vs. income of A$493 thousand. Revenues reflect an increased market penetration in the US and strong growth in Australia. Net loss reflects costs associated with promotion efforts in the US.
More from Market Guide: Significant Developments

Officers

Position
Graham Kelly, Ph.D.Chairman
David SeatonCFO
Chris NaughtonManaging Director
Warren LancasterVice-Pres
Ronald ErrattSec.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NVGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-July-2001
$3.35 
Recent Price$3.70 
52-Week High
on 5-Sep-2000
$12.25 
Beta1.15 
Daily Volume (3-month avg)29.7K
Daily Volume (10-day avg)18.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-67.8%
52-Week Change
relative to S&P500
-56.8%
Share-Related Items
Market Capitalization$59.0M
Shares Outstanding15.9M
Float7.64M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book ValueN/A 
Earnings (ttm)-$0.82 
EarningsN/A 
SalesN/A 
CashN/A 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDAN/A 
IncomeN/A 
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-1999
Management Effectiveness
Return on AssetsN/A 
Return on EquityN/A 
Financial Strength
Current RatioN/A 
Debt/EquityN/A 
Total CashN/A 
Short Interest
As of 8-Aug-2001
Shares Short21.0K
Percent of Float0.3%
Shares Short
(Prior Month)
21.0K
Short Ratio4.20 
Daily Volume5,000 
ADR Information
Shares/ADR5
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-1999);   dollar amounts based on an exchange rate of 1.89 Australian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.